Korean J Lab Med.  2002 Oct;22(5):295-298.

Four Cases of Myelodysplastic Syndrome with Systemic Lupus Erythematosus

Affiliations
  • 1Department of Laboratory Medicine, College of Medicine, Catholic University, Korea. sgkim@cataegu.ac.kr
  • 2Department of Internal Medicine, College of Medicine, Catholic University, Korea.
  • 3Department of Internal Medicine, Fatima Hospital, Daegu, Korea.

Abstract

Systemic lupus erythematosus (SLE) has been a well-known systemic autoimmune disease with hematologic abnormalities such as anemia, leukopenia, and thrombocytopenia. Myelodysplastic syndrome (MDS) is defined as a clonal expansion of BM derived pluripotent stem cells. Although SLE and MDS are independent disease entities, there have been several reports regarding rheumatic manifestations of MDS, which suggest that there might be a relationship between these two diseases in the pathogenetic sequence. We reviewed our cases of MDS and SLE and encountered four patients with both MDS and SLE, both of which developed concurrently. They were all women from 15 to 50 years old. They had anemia or pancytopenia. Bone marrow findings were disclosed as MDS, RA or hypoplastic MDS, RA. They had positive ANA at a titer above 1:160 of homogeneous, speckled, or dense cytoplasmic pattern. Double-stranded DNA levels increased in all cases, whereas serum complement and immunoglobulin levels were decreased except in case 1.

Keyword

MDS; SLE; Stem cell; Donble-stranded DNA

MeSH Terms

Anemia
Autoimmune Diseases
Bone Marrow
Complement System Proteins
Cytoplasm
DNA
Female
Humans
Immunoglobulins
Leukopenia
Lupus Erythematosus, Systemic*
Middle Aged
Myelodysplastic Syndromes*
Pancytopenia
Pluripotent Stem Cells
Stem Cells
Thrombocytopenia
Complement System Proteins
DNA
Immunoglobulins
Full Text Links
  • KJLM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr